150 related articles for article (PubMed ID: 20128377)
1. [Plasma endothelin level in hypertensive patients receiving standard anti-hypertensive therapy with or without statins].
Liu XH; Li YF; Lai CL; Ji YR; Zhao JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):800-3. PubMed ID: 20128377
[TBL] [Abstract][Full Text] [Related]
2. [Effect of simvastatin on cardiac fibrosis in patients with essential hypertension].
Zhang GG; Zhang SD
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):280-2. PubMed ID: 16045013
[TBL] [Abstract][Full Text] [Related]
3. [Effects of losartan on left ventricular hypertrophy and plasma transforming growth factor-beta1 in elderly patients with hypertension].
Wu ZL; Xu DL; Li Y; Lai WY; Huang P; Bai SC; Su L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):531-3. PubMed ID: 19304546
[TBL] [Abstract][Full Text] [Related]
4. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
Skalska AB; Pietrzycka A; Stepniewski M
Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960
[TBL] [Abstract][Full Text] [Related]
5. [Serum uric acid prevalence and changes post various antihypertensive agents in patients with essential hypertension].
Chen H; Yang LQ; Yu L; Wu XY; Lu LH; Gui W
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):523-6. PubMed ID: 19100066
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. Impacts of lisinopril and lisinopril plus simvastatin on erythrocyte and plasma arginase, nitrite, and nitrate in hypertensive patients.
Kosenko E; Tikhonova L; Suslikov A; Kaminsky Y
J Clin Pharmacol; 2012 Jan; 52(1):102-9. PubMed ID: 21406601
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive therapy on left atrial function.
Dernellis JM; Vyssoulis GP; Zacharoulis AA; Toutouzas PK
J Hum Hypertens; 1996 Dec; 10(12):789-94. PubMed ID: 9140783
[TBL] [Abstract][Full Text] [Related]
11. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension.
Zhao S; Li Q; Liu L; Xu Z; Xiao J
Clin Chim Acta; 2004 Jun; 344(1-2):195-200. PubMed ID: 15149889
[TBL] [Abstract][Full Text] [Related]
13. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
14. [Effect of antihypertensive agents on plasma endothelin, nitric oxide and so on in essential hypertension].
Chen S; Liu G; Yang T
Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):587-90. PubMed ID: 10436966
[TBL] [Abstract][Full Text] [Related]
15. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
[TBL] [Abstract][Full Text] [Related]
16. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia.
Lewandowski J; Siński M; Bidiuk J; Abramczyk P; Dobosiewicz A; Ciarka A; Gaciong Z
Hypertens Res; 2010 Oct; 33(10):1038-43. PubMed ID: 20668455
[TBL] [Abstract][Full Text] [Related]
18. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Ichihara A; Hayashi M; Koura Y; Tada Y; Kaneshiro Y; Saruta T
J Hum Hypertens; 2005 Feb; 19(2):103-9. PubMed ID: 15361892
[TBL] [Abstract][Full Text] [Related]
20. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
